[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.172.195.49. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Original Investigation
February 14, 2011

Resource Use in the Last 6 Months of Life Among Patients With Heart Failure in Canada

Author Affiliations

Author Affiliations: Department of Medicine, Divisions of Cardiology (Drs Kaul, Ezekowitz, Bakal, and Armstrong) and General Internal Medicine (Dr McAlister), and Mazankowski Alberta Heart Institute (Drs Kaul, McAlister, Ezekowitz, and Armstrong) University of Alberta, Edmonton, Alberta, Canada; Departments of Community Health Sciences (Dr Quan) and Medicine (Dr Knudtson), University of Calgary, Calgary, Alberta; and Center for Clinical and Genetic Economics, Duke Clinical Research Institute, and Department of Medicine, Duke University School of Medicine, Durham, North Carolina (Dr Curtis).

Arch Intern Med. 2011;171(3):211-217. doi:10.1001/archinternmed.2010.365

Heart failure (HF) is a debilitating and chronic condition associated with significant morbidity and mortality. More than 500 000 Canadians live with HF, and approximately 50 000 new patients are diagnosed each year.1 Often considered a disease of elderly individuals, the prevalence of HF increases notably with age. In 2003, 0.2% of Canadians younger than 50 years reported having HF; the corresponding figure for those 80 years or older was 6.7%.2 Rates of HF are expected to increase exponentially in coming years as a result of several factors, including the aging of the Canadian population, improved survival rates after myocardial infarction, and the development of new therapies for more effective treatment of those with HF.3-5 Quality of life for patients with HF is frequently poor, and long-term prognosis includes a 5-year mortality rate of 69% among hospitalized patients in the community.6-8

×